SINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey...

Cambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...

Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development SINGAPORE, BOSTON and SHANGHAI...

SINGAPORE – 27 May 2022. EVX Ventures (“EVX”), a life sciences venture builder headquartered in Singapore with operations in Boston and...

We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:

Advancing the next generation of cell and gene therapies via a “platform of platforms” model SINGAPORE, Nov. 1, 2021 /PRNewswire/ --...

SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies,...

CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don...

REDWOOD CITY, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company,...

Carmine Therapeutics has been named as one of FierceBiotech’s “Fierce 15” Biotech companies of 2020, designating it as one of the most promi